Surgery for midgut carcinoid

Endocrine-Related Cancer

Volumn 10, Issue 4, 2003, Pages 469-481

  Sutton, R ^a   Doran, H E ^a   Williams, E M I ^a   Vora, J ^b   Vinjamuri, S ^b   Evans, J ^b   Campbell, F ^b   Raraty, M G T ^a   Ghaneh, P ^a   Hartley, M ^b   Poston, G J ^b   Neoptolemos, J P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CATECHOLAMINE; CHROMOGRANIN A; SEROTONIN; SOMATOSTATIN RECEPTOR; SUBSTANCE P; TUMOR MARKER;

APPENDECTOMY; CANCER RISK; CANCER SURVIVAL; CARCINOID; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ELECTIVE SURGERY; EMERGENCY TREATMENT; EPIDEMIOLOGICAL DATA; HEMICOLECTOMY; HISTOPATHOLOGY; HUMAN; LIVER RESECTION; LIVER TRANSPLANTATION; MIDGUT; PROGNOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; VALVULAR HEART DISEASE;

CARCINOID TUMOR; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL NEOPLASMS; HUMANS;

EID: 0347719195     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0100469     Document Type: Conference Paper

References (110)

1. Ahlman H 1996 The role of surgery in patients with advanced midgut carcinoid tumours. Digestion 57 (Suppl 1) 86-87.
2. Anderson JR & Wilson BG 1985 Carcinoid tumours of the appendix. British Journal of Surgery 72 545-546.
3. Anthony PP & Drury RA 1970 Elastic vascular sclerosis of mesenteric blood vessels in argentaffin carcinoma. Journal of Clinical Pathology 23 110-118.
4. Ballantyne GH, Savoca PE, Flannery JT, Ahlman MH & Modlin IM 1992 Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 69 2400-2405.
5. Bechstein WO & Neuhaus P 1994 Liver transplantation for hepatic metastases of neuroendocrine tumors. Annals of the New York Academy of Sciences 733 507-514.
6. Berge T & Linell F 1976 Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathologica Microbiologica Scandinavia 84 322-330.
7. Burke AP, Thomas RM, Elsayed AM & Sobin LH 1997 Carcinoids of the jejunum and ileum. Cancer 79 1086-1093.
8. Caplin ME, Buscombe JR, Hilson A, Jones AL, Watkinson A & Burroughs AK 1998 Carcinoid tumour. Lancet 352 799-805.
9. Chamberlain RS, Canes D, Brown KT, Saltz L, Jamagin W, Fong Y & Blumgart LH 2000 Hepatic neuroendocrine metastases: does intervention alter outcomes? Journal of the American College of Surgeons 190 432-445.
10. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
11. Chen H, Hardacre JM, Uzar A, Cameron JL & Choti MM 1998 Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? Journal of the American College of Surgeons 187 88-93.
12. Chung MH, Pisegna J, Spirt M, Giuliano AE, Ye W, Ramming KP & Bilchik AJ 2001 Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver. Surgery 130 954-962.
13. Connolly HM, Schaff HV, Mullany CJ, Abel MD & Pellikka PA 2002 Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling. Circulation 106 (Suppl 1) 151-156.
14. Cunningham JD, Aleali R, Aleali M, Brower ST & Aufses AH 1997 Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Annals of Surgery 225 300-306.
15. Di Luzio S & Rigolin VH 2000 Carcinoid heart disease. Current Treatment Options in Cardiovascular Medicine 2 399-406.
16. DiSario JA, Burt RW, Kendrick ML & McWhorter WP 1994 Colorectal cancers of rare histologic types compared with adenocarcinomas. Diseases of the Colon and Rectum 37 1277-1280 [Erratum in Diseases of the Colon and Rectum 1995 38 1227].
17. DiSario JA, Burt RW, Kendrick ML & McWhorter WP 1994 Colorectal cancers of rare histologic types compared with adenocarcinomas. Diseases of the Colon and Rectum 37 1277-1280 [Erratum in Diseases of the Colon and Rectum 1995 38 1227].
18. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA & Norton JA 1998 Lethality of multiple endocrine neoplasia type I. World Journal of Surgery 22 581-587.
19. Dougherty TB & Cronau LH Jr 1998 Anesthetic implications for surgical patients with endocrine tumors. International Anesthesiology Clinics 36 31-44.
20. Eckhauser FE, Argenta LC, Strodel WE, Wheeler RH, Bull FE, Appelman HD & Thompson NW 1981 Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 90 720-728.
21. Eriksson B, Oberg K & Stridsberg M 2000 Tumor markers in neuroendocrine tumors. Digestion 62 33-38.
22. Facco C, La-Rosa S, Dionigi A, Uccella S, Riva C & Capella C 1998 High expression of growth factors and growth factor receptors in ovarian metastases from ileal carcinoids: an immunohistochemical study of 2 cases. Archives of Pathological and Laboratory Medicine 122 828-832.
23. Falconi M, Bettini R, Scarpa A, Capelli P & Pederzoli P 2001 Surgical strategy in the treatment of gastrointestinal neuroendocrine tumours. Annals of Oncology 12 (Suppl 2) S101-S103.
24. Godwin JD II 1975 Carcinoid tumors. An analysis of 2837 cases. Cancer 36 560-569.
25. Gortz B, Roth J, Krahenmann A, de Krijger RR, Muletta-Feurer S, Rutimann K, Saremaslani P, Speel EJ, Heitz PU & Komminoth P 1999 Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. American Journal of Pathology 154 429-436.
26. Hellman P, Ladjevardi S, Skogseid B, Akerstrom G & Elvin A 2002 Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World Journal of Surgery 26 1052-1056.
27. Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF & Vauthey JN 2003 Preoperative portal vein embolization for extended hepatectomy. Annals of Surgery 237 686-693.
28. Hemminki K & Li X 2001a Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 92 2204-2210.
29. Hemminki K & Li X 2001b Familial carcinoid tumors and subsequent cancers: a nation-wide epidemiologic study from Sweden. International Journal of Cancer 94 444-448.
30. Holdcroft A 2000 Hormones and the gut. British Journal of Anaesthesia 85 58-68.
31. Kaltsas GA, Mukherjee JJ & Grossman AB 2001 The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours. Annals of Oncology 12 S47-S50.
32. Kent RB III, van Heerden JA & Weiland LH 1981 Nonfunctioning islet cell tumors. Annals of Surgery 193 185-190.
33. Khuri SF, Daley J, Henderson W, Hur K, Gibbs JO, Barbour G, Demakis J, Irvin G III, Stremple JF, Grover F et al. 1997 Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. Journal of the American College of Surgeons 185 315-327.
34. Kimura W, Kuroda A & Morioka Y 1991 Clinical pathology of endocrine tumours of the pancreas: analysis of autopsy cases. Digestive Diseases and Sciences 36 933-942.
35. Kowlessar OD, Law DH & Sleisenger MH 1959 Malabsorption syndrome associated with metastatic carcinoid tumor. American Journal of Medicine 27 673-677.
36. Kinney MA, Warner ME, Nagorney DM, Rubin J, Schroeder DR, Maxson PM & Warner MA 2001 Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. British Journal of Anaesthesia 87 447-452.
37. Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausema L, Lameris JS, Reubi JC & Lamberts SW 1989 Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1 242-244.
38. Krenning EP, de Jong M, Kooij PP, Breeman WA, Bakker WH, de Herder WW, van Eijck CH, Kwekkeboom DJ, Jamar F, Pauwels S et al. 1999 Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy. Annals of Oncology 10 S23-S29.
39. Kulke M & Mayer R 1999 Carcinoid tumors. New England Journal of Medicine 340 858-868.
40. Kvols LK, Martin JK, Marsh HM & Moertel CG 1985 Rapid reversal of carcinoid crisis with a somatostatin analogue. New England Journal of Medicine 313 1229-1230.
41. Lam KY & Lo CY 1997 Pancreatic endocrine tumours: a 22 year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. European Journal of Surgical Oncology 23 36-42.
42. Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GFW, Flemming P, Ringe B & Pichlmayr R 1997 Liver transplantation for metastatic neuroendocrine tumors. Annals of Surgery 225 347-354.
43. Le Treut PY, Delpero JR, Dousset B, Cherqui D, Segol P, Mantion G, Hannoun L, Benhamou G, Launois B, Boillot O et al. 1997 Results of liver transplantation in the treatment of metastatic neuroendocrine tumours. Annals of Surgery 225 335-364.
44. Lehnert T 1998 Liver transplantation for metastatic neuroendocrine carcinoma. Transplantation 66 1307-1312.
45. Lembeck F 1953 5-Hydroxytryptamine in a carcinoid tumour. Nature 172 910-911.
46. Levi F, Randimbison L, Franceschi S & LaVecchia C 1993 Descriptive epidemiology of malignant carcinoids in the Swiss Canton of Vaud. International Journal of Cancer 53 1036-1037.
47. Levi F, Te V, Randimbison L, Rindi G & La Vecchia C 2000 Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-1997. British Journal of Cancer 70 939-942.
48. Lollgen RM, Hessman O, Szabo E, Westin G & Akerstrom G 2001 Chromosome 18 deletions are common events in classical midgut carcinoid tumors. International Journal of Cancer 92 812-815.
49. Lundqvist M & Wilander E 1987 A study of histopathogenesis of carcinoid tumors of the small intestine and appendix. Cancer 60 201-206.
50. McCusker ME, Coté TR, Clegg LX & Sobin LH 2002 Primary malignant neoplasms of the appendix: a population-based study from the Surveillance, Epidemiology and End-Results Program, 1973-1998. Cancer 94 3307-3312.
51. McDermott EW, Guduric B & Brennan MF 1994 Prognostic variables in patients with gastrointestinal carcinoid tumours. British Journal of Surgery 81 1007-1009.
52. MacGillivray DC, Synder DA, Drucker W & ReMine SG 1991 Carcinoid tumors: the relationship between clinical presentation and the extent of disease. Surgery 110 68-72.
53. Makridis C, Oberg K, Juhlin C, Rastad J, Johansson H, Lorelius LE & Akerstrom G 1990 Surgical treatment of mid-gut carcinoid tumors. World Journal of Surgery 14 377-383.
54. Makridis C, Ekbom A, Bring J, Rastad J, Juhlin C, Oberg K & Akerstrom G 1997 Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery 122 1075-1082.
55. Meijer WG, Kema IP, Volmer M, Willemse PHB & de Vries EGE 2000 Discriminating capacity of indole markers in the diagnosis of carcinoid tumours. Clinical Chemistry 46 1588-1596.
56. Modlin IM & Sandor A 1997 An analysis of 8305 cases of carcinoid tumors. Cancer 79 813-829.
57. Modlin IM, Lye KD & Kidd M 2003 A 5-decade analysis of 13 715 carcinoid tumors. Cancer 97 934-959.
58. Moertel CG & Dockerty MB 1973 Familial occurrence of metastasizing carcinoid tumors. Annals of Internal Medicine 78 389-390.
59. Moertel CG, Dockerty MB & Judd ES 1968 Carcinoid tumors of the vermiform appendix. Cancer 21 270-278.
60. Moertel CG, Weiland LH, Nagomey DM & Dockerty MB 1987 Carcinoid tumor of the appendix: treatment and prognosis. New England Journal of Medicine 317 1699-1701.
61. Morgan JG, Marks C & Hearn D 1974 Carcinoid tumors of the gastrointestinal tract. Annals of Surgery 180 720-727.
62. Moyssakis IE, Rallidis LS, Guida GF & Nihoyannopoulos PI 1997 Incidence and evolution of carcinoid syndrome in the heart. Journal of Heart Valve Disease 6 625-630.
63. Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P & Reynolds DJ 1994 The epidemiology of carcinoid tumours in England and Scotland. British Journal of Cancer 70 939-942.
64. Nilsson O, Gronstad KO, Goldstein M, Skolnik G, Dahlstrom A & Ahlman H 1985 Adrenergic control of serotonin release from a midgut carcinoid tumour. International Journal of Cancer 36 307-312.
65. Norheim I, Oberg K, Theodorsson-Norheim E, Lindgren PG, Lundqvist G, Magnusson A, Wide L & Wilander E 1987 Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Annals of Surgery 206 115-125.
66. Norton JA 1994 Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 55 98-103.
67. Oberg K 1994 Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Annals of the New York Academy of Sciences 733 46-55.
68. Obemdorfer S 1907 Karzenoide tumoren des dünndarms. Frankfurt Zeitschrift Pathologie 1 426-430.
69. Ohrvall U, Eriksson B, Juhlin C, Karacagil S, Rastad J, Hellman P & Akerstrom G 2000 Method for dissection of mesenteric metastases in mid-gut carcinoid tumors. World Journal of Surgery 24 1402-1408.
70. Olausson M, Friman S, Cahlin C, Nilsson O, Jansson S, Wangberg B & Ahlman H 2002 Indications and results of liver transplantation in patients with neuroendocrine tumors. World Journal of Surgery 26 998-1004.
71. Oliveira AM, Tazelaar HD, Wentzlaff KA, Kosugi NS, Hai N, Benson A, Miller DL & Yang P 2001 Familial pulmonary carcinoid tumors. Cancer 91 2104-2109.
72. Onaitis MW, Kirshbom PM, Hayward TZ, Quayle FJ, Feldman JM, Seigler HF & Tyler DS 2000 Gastrointestinal carcinoids: characterization by site of origin and hormone production. Annals of Surgery 232 549-556.
73. Orlefors H, Sundin A, Ahlstrom H, Bjurling P, Bergstrom M, Lilja A, Langstrom B, Oberg K & Eriksson B 1998 Positron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors. Journal of Clinical Oncology 16 2534-2541.
74. Pemow B & Waldenström J 1954 Paroxysmal flushing and other symptoms caused by 5-hydroxytryptamine and histamine in patients with malignant tumours. Lancet 2 951-956.
75. Pope I & Poston GJ 2003 Management of neuroendocrine tumours. In Surgical Management of Hepatobiliary and Pancreatic Disorders, edn 1, pp 151-172. Eds GJ Poston & LH Blumgart. London: Martin Dunitz.
76. Primatesta P & Goldacre MJ 1994 Appendicectomy for acute appendicitis and for other conditions: an epidemiological study. International Journal of Epidemiology 23 155-160.
77. Quaedvlieg PFHJ, Visser O, Lamers CBHW, Janssen-Heijen MLG & Taal BG 2001 Epidemiology and survival in patients with carcinoid disease in the Netherlands: an epidemiological study with 2391 patients. Annals of Oncology 12 1295-1300.
78. Robiolio PA, Rigolin VH, Harrison JK, Lowe JE, Moore JO, Bashore TM & Feldman JM 1995 Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. American Journal of Cardiology 75 485-488.
79. Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, Lang H, Klempnauer J, Manns MP & Boeker KH 2002 Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 73 386-394.
80. Ross EM & Roberts WC 1985 The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. American Journal of Medicine 79 339-354.
81. Saha S, Hoda S, Godfrey R, Sutherland C & Raybon K 1989 Carcinoid tumors of the gastrointestinal tract: a 44-year experience. Southern Medical Journal 82 1501-1505.
82. Sandor A & Modlin IM 1998 A retrospective analysis of 1570 appendiceal carcinoids. American Journal of Gastroenterology 93 422-428.
83. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM & Que FG 2003 Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. Journal of the American College of Surgeons 197 29-37.
84. Shebani KO, Souba WW, Finkelstein DM, Stark PC, Elgadi KM, Tanabe KK & Ott MJ 1999 Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Annals of Surgery 229 815-823.
85. Soga J 1997 Carcinoids of the small intestine: a statistical evaluation of 1102 cases collected from the literature. Journal of Experimental and Clinical Cancer Research 16 353-363.
86. Soga J 1998a Statistical evaluation of 2001 carcinoid cases with metastases, collected from the literature: a comparative study between ordinary carcinoids and atypical varieties. Journal of Experimental and Clinical Cancer Research 17 3-12.
87. Soga J 1998b Carcinoids of the colon and ileocecal region: a statistical evaluation of 363 cases collected from the literature. Journal of Experimental and Clinical Cancer Research 17 139-148.
88. Solcia E, Klöppel G & Sobin LH 2000 World Health Organisation International Histologic Classification of Tumours: Histologic Typing of Endocrine Tumours, edn 2. Berlin: Springer Verlag.
89. Soreide O, Berstad T, Bakka A, Schrumpf E, Hanssen LE, Engh V, Bergan A & Flatmark A 1992 Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111 48-54.
90. Stinner B, Kisker O, Zielke A & Rothmund M 1996 Surgical management for carcinoid tumors of small bowel, appendix, colon and rectum. World Journal of Surgery 20 183-188.
91. Stridsberg M, Hellman U, Wilander E, Lundqvist G, Hellsing K & Oberg K 1993 Fragments of chromogranin A are present in the urine of patients with carcinoid tumors: development of a specific radioimmunoassay for chromogranin A and its fragments. Journal of Endocrinology 139 329-337.
92. Subbuswamy SG, Gibbs NM, Ross CF & Morson BC 1974 Goblet cell carcinoid of the appendix. Cancer 34 338-344.
93. Talamonti MS, Goetz LH, Rao S & Joehl RJ 2002 Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management. Archives of Surgery 137 564-571.
94. Thakker RV 2001 Multiple endocrine neoplasia. Hormone Research 56 67-72.
95. Thompson GB, van Heerden JA, Martin JK Jr, Schutt AJ, Ilstrup DM & Carney JA 1985 Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery 98 1054-1063.
96. Thorson A, Biorek G, Bjorkman O & Waldenstorm J 1954 Malignant carcinoid of the small intestine with metastasis to liver, valvular disease of right side of heart (pulmonary stenosis and tricuspid regurgitation without septal defect), peripheral vasomotor symptoms, bronchoconstriction, and unusual type of cyanosis; clinical and pathologic syndrome. American Heart Journal 48 795-817.
97. Thulin L, Samnegard H, Tyden G, Long DH & Efendic S 1978 Efficacy of somatostatin in a patient with carcinoid syndrome [letter]. Lancet 2 43.
98. Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB & Van Velthuysen ML 2002 Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Human Pathology 33 1126-1132.
99. Venook AP 1999 Embolization and chemoembolization therapy for neuroendocrine tumors. Current Opinion in Oncology 11 38-41.
100. Wängberg B, Westberg G, Tylén U, Tisell L-E, Jansson S, Nilsson O, Johansson V, Scherstén T & Ahlman H 1996 Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World Journal of Surgery 20 892-899.
101. Warner TF, O'Reilly G & Lee GA 1979 Mesenteric occlusive lesion and ileal carcinoids Cancer 44 758-762.
102. Watson RG, Johnston CF, O'Hare MM, Anderson JR, Wilson BG, Collins JS, Sloan JM & Buchanan KD 1989 The frequency of gastrointestinal endocrine tumours in a well-defined population -Northern Ireland 1970-1985. Quarterly Journal of Medicine 72 647-657.
103. Westberg G, Wängberg B, Ahlman H, Bergh CH, Beckman-Suurkula M & Caidahl K 2001 Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. British Journal of Surgery 88 865-872.
104. Westergaard T, Frisch M & Melbye M 1995 Carcinoid tumors in Denmark 1978-1989 and the risk of subsequent cancers. A population-based study. Cancer 76 106-109.
105. Wilder RM, Allen FN, Power MH & Robertson HE 1927 Carcinoma of islands of pancreas, hyperinsulinism and hypoglycemia. Journal of the American Medical Association 89 348-355.
106. Williams ED & Sobin M 1963 The classification of carcinoid tumours. Lancet 1 238-239.
107. World Health Organisation 1990 International Classification of Diseases for Oncology: Morphology of Neoplasms, edn 2. Geneva: World Health Organisation.
108. Yao KA, Talamonti MS, Nemcek A, Angelos P, Chrisman H, Skarda J, Benson AB, Rao S & Joehl RJ 2001 Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130 677-685.
109. Yeatman TJ, Sharp JV & Kimura AK 1989 Can susceptibility to carcinoid tumors be inherited? Cancer 63 390-393.
110. Zollinger RM & Ellison EH 1955 Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Annals of Surgery 142 709-728.